SILO PHARMA, INC. Investment Owned, at Fair Value
SILO PHARMA, INC. (SILO) had Investment Owned, at Fair Value of $391.70 thousand as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Financial Services › Investment Company
us-gaap:InvestmentOwnedAtFairValue · last filed 2019-04-04
- 2018-09-30: Investment Owned, at Fair Value $391.70K.
- 2017-12-31: Investment Owned, at Fair Value $1.32M.
- 2013-12-31: Investment Owned, at Fair Value $196.16K.
| Period end | Investment Owned, at Fair Value |
|---|---|
| 2018-09-30 | $391.70K 10-Q · filed 2018-11-14 |
| 2017-12-31 | $1.32M 10-K · filed 2019-04-04 |
| 2013-12-31 | $196.16K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |